HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Edonerpic

HCID 9901946
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
519187-23-6
Standard SMILES
OC1CN(CCCOCCc2ccc3sccc3c2)C1
InChIKey
HQNACSFBDBYLJP-UHFFFAOYSA-N
Molecular formula
C16H21NO2S
Average molar mass
291.4 g/mol

Overview

Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.

Names & identifiers

Preferred name
Edonerpic
IUPAC
1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol
English name
3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-
Molecular formula
C16H21NO2S
Molecular weight
291.41

Names & synonyms

Edonerpic519187-23-61-(3-(2-(Benzo[b]thiophen-5-yl)ethoxy)propyl)azetidin-3-olT-817Edonerpic [INN]Edonerpic [WHO-DD]QY49O94S2WUNII-QY49O94S2W1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}azetidin-3-ol1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol3-Azetidinol, 1-(3-(2-benzo(b)thien-5-ylethoxy)propyl)-3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-
Show more names
T817Edenorpic free base1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)-3-azetidinol
1-(3-(2-(Benzo(b)thiophen-5-yl)ethoxy)propyl)azetidin-3-oledonerpicoedonerpicum1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-olRefChem:136297J2.972.359AMFCD28502068edonerpic-maleate

Database identifiers

CAS
519187-23-6
PubChem CID
9901946
ChEMBL

Properties

Computed structural properties

XLogP
2.6
Topological polar surface area
60.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
7
Heavy atoms
20
Formal charge
0
Complexity
296

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
451.1 · 451.1±45.0 °C(Predicted)
Density
1.23 · 1.230±0.06 g/cm3(Predicted)
pka
14.34 · 14.34±0.20(Predicted)
FDA UNII
49 O94S2W · QY49O94S2W

Chemistry & industry

Pharmacology

Mechanism of Action · 1 item

T-817MA has neuroprotective properties. Toyama Chemical has demonstrated that T-817MA prevents neurodegeneration induced by Amyloid-b protein. Accumulation of Amyloid-b protein is considered to be central to the pathogenesis of Alzheimer's disease. The neuroprotective properties of T-817MA were also observed in a mutant tau induced Alzheimer's disease model. Besides these neuroprotective properties, T-817MA also promotes neurite outgrowth.

Suppliers6 total

上海冬洋生物科技有限公司0512-13601744364 13601744364
HANGZHOU LEAP CHEM CO., LTD.+86-571-87711850 +86-15355479329 · [email protected]
苏州美石生物科技有限公司1173954148q · [email protected]
上海超岚化工科技中心QQ:65489617 13301690235 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
上海相辉医药科技有限公司13611835272 13611835272 · [email protected]

Related reactions

30 records
New reaction record
HRID 7440 reaction equation
HRID 7440As productuspto-grants-2006_08
HRID 7451 reaction equation
HRID 7451As reactantuspto-grants-2006_08
HRID 7452 reaction equation
HRID 7452As reactantuspto-grants-2006_08
HRID 7453 reaction equation
HRID 7453As reactantuspto-grants-2006_08
HRID 7454 reaction equation
HRID 7454As reactantuspto-grants-2006_08
HRID 562382 reaction equation
HRID 562382As productuspto-grants-2011_11
HRID 562383 reaction equation
HRID 562383As reactantuspto-grants-2011_11
HRID 597809 reaction equation
HRID 597809As productuspto-grants-2011_03
Page 1 of 4

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
CHEMBL4302089
UNII
QY49O94S2W
Nikkaji
J2.972.359A